Before you watch this webinar
Enhancing your learning experience begins with understanding you better. Collecting data enables us to tailor our educational content specifically for our audience. Discover more about how we handle your information in our Privacy Policy.
This area of the website is reserved for healthcare professionals as it contains information created for a healthcare professional audience.
Event
New insights in managing myasthenia gravis in the clinic: what do you need to know?
Please note: There is restricted access to the live webinars. Access to the live webinars is for health professionals and a limited number of pharmaceutical representatives. If you are not granted access to the live webinar, you will be able to review a recording of the Neuromuscular Academy session, which will be posted on our website shortly after the webinar has been conducted.
Our sponsor

This webinar has received sponsorship from UCB Pharma Limited. The first session in the webinar is designed and delivered by the Neuromuscular Academy and sponsored by UCB Pharma Limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by UCB Pharma Limited. This satellite symposium is for UK Healthcare Professionals only.
Neuromuscular Academy will host a live webinar on Thursday 16th July at 16:15 BST. You are invited to watch the webinar from your computer or tablet. We will be live for 1 hour and 50 minutes via Zoom and a recording of the Neuromuscular Academy session will be available following the meeting.
16:15 - 17:15 - Neuromuscular Academy webinar
17:15 - 17:20 - Break
17:20 - 18:05 - UCB Pharma Limited promotional satellite symposium
Neuromuscular Academy session:
New insights in managing myasthenia gravis in the clinic: what do you need to know?
Objectives:
- How will the updated guidance on myasthenia gravis management in the UK be used in clinics.
- The impact of using Rituximab in managing myasthenia gravis: can early use be helpful
- Understanding novel therapies in managing refractory MG.
Dr Channa Hewamadduma
Consultant neurologist and honorary senior lecturer, Sheffield Teaching Hospitals NHS Foundation Trust
Prof Saiju Jacob
Consultant neurologist, University Hospitals Birmingham

This webinar has received sponsorship from UCB Pharma Limited. The first session in the webinar is designed and delivered by the Neuromuscular Academy and sponsored by UCB Pharma Limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by UCB Pharma Limited. UCB products will be mentioned during this symposium. This satellite symposium is for UK Healthcare Professionals only.
UCB Pharma Limited promotional satellite symposium:
Targeted therapies in gMG: Interpreting guidelines and evidence to optimise patient outcomes
Objectives:
To interpret current guidelines and emerging evidence on targeted therapies in generalized myasthenia gravis (gMG) and apply these insights to inform personalized treatment decisions that improve patient outcomes
UCB products will be mentioned during this symposium
GB-DA-2600203 | July 2026
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/Yellowcard. Adverse events should also be reported to UCBPharma Ltd at ucbcares.uk@ucb.com or 0800 2793177.
Speakers TBC
This event is free to attend as a result of sponsorship from our sponsors. The current event sponsors are listed on this page. In the interest of Neurology Academy and our sponsors’ legitimate business interests, we make available your name, job title and workplace to our sponsors. It allows us to attract the most appropriate sponsors, delegates and speakers for the events and to facilitate potential collaboration and communication between you and the sponsors; and allows us to offer other relevant events and services to the healthcare and life science industries. You can ask us not to share your name, job title and workplace by emailing info@neurologyacademy.org. We respect the privacy of every person for whom we have personal data. The group privacy and cookies policy can be viewed here.
Book your place now
Our sponsor

This webinar has received sponsorship from UCB Pharma Limited. The first session in the webinar is designed and delivered by the Neuromuscular Academy and sponsored by UCB Pharma Limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by UCB Pharma Limited. This satellite symposium is for UK Healthcare Professionals only.
Raising awareness, improving outcomes
Neuromuscular Academy is the first bespoke course for healthcare professionals to receive expert training in neuromuscular conditions like spinal muscular atrophy.

